Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs PMGC Holdings Inc. (ELAB)

Artelo Biosciences, Inc. and PMGC Holdings Inc. are both Biotechnology companies. PMGC Holdings Inc. is the larger, with a market value of $1.3M against $1.2M — 1.1× the size. Artelo Biosciences, Inc. has the higher net margin (0.00% vs −523.0%) and the lower return on invested capital (−865.9% vs 0.00%). Across the 15 metrics below, Artelo Biosciences, Inc. leads on 8 and PMGC Holdings Inc. on 7.

Valuation

Metric ARTL ELAB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.31 9.40
P/B 0.12 0.05 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 1.58 0.66
EV/Sales n/m (6.87) 9.02
Earnings yield (10,336.94%) (127,538.28%) (32.88%)
Free cash flow yield (2,139.52%) (1,131.30%) (23.13%)

Profitability

Metric ARTL ELAB Biotechnology median
Gross margin 0.00% 31.08% 68.51%
Operating margin 0.00% (458.63%) 0.00%
Net margin 0.00% (522.99%) 0.00%
Free cash flow margin 0.00% (348.69%) 0.00%
Return on equity (705.71%) (104.60%) (51.96%)
Return on assets (234.30%) (58.71%) (46.06%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL ELAB Biotechnology median
Revenue growth (TTM) — 5.41% 6.76%
EPS growth (last fiscal year) 31.57% 94.22% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ARTL ELAB Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 3.00 1.36 4.97
Net debt to EBITDA 0.05 0.87 1.01

Dividend

Metric ARTL ELAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTL ELAB Biotechnology median
Market cap 1.16m 1.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack